Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor–Induced Thyroiditis

BACKGROUND/OBJECTIVE: Immune checkpoint inhibitors (CPIs) activate antitumoral immune responses and are used to treat multiple types of primary and metastatic malignancies. Thyroid dysfunction is a known immune-related adverse event of CPI therapy. There are few data on the effect of CPI and CPI-ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dennis H., Lenz, Heinz-Josef, Lechner, Melissa G., Angell, Trevor E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509378/
https://www.ncbi.nlm.nih.gov/pubmed/37736314
http://dx.doi.org/10.1016/j.aace.2023.05.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509378/
https://www.ncbi.nlm.nih.gov/pubmed/37736314
http://dx.doi.org/10.1016/j.aace.2023.05.009

Ejemplares similares